Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Promoting Sleep: Not a Leap

Oct 1, 2018/Feature

When PTs snooze on broaching the subject of sleep health, patients and clients lose.

APTA, Provider and Patient Groups Push Major Reforms to Prior Authorization

Mar 25, 2026/News

APTA has joined a broad coalition of national provider and patient organizations to release a new policy framework aimed at tackling one of the most persistent barriers to timely therapy: the misuse of prior authorization and utilization review.   The new framework, titled "Care Delayed Is Care Denied:

Credentialed Clinical Instructor Program Level 1

This program provides enhanced clinical education skills for instructors, CEUs, and, for PTs and PTAs, a prestigious CI credential.

Patellofemoral Pain

May 2, 2024/Clinical Summary

PTs evaluate and commonly provide treatment for patients with PFP, managing pain and restoring patellofemoral function.

A Healthy Perspective

Mar 1, 2017/Column

Helping clients take a longer view.

TRICARE: The US Military's Health Care Program

Dec 1, 2016/Column

A look at 2 issues: Are PTAs reimbursable? Also, regions will consolidate.

Compliance Matters: Habilitative Versus Rehabilitative Services: What's the Difference?

Nov 1, 2017/Column

Here's what PTs need to know, and why it's important.

For Facilities, What About Telehealth Post-PHE? APTA Presses CMS for Answers

May 9, 2023/News

With the end of the health emergency looming, APTA, AOTA, and ASHA are urging CMS to eliminate a gap in its extension of telehealth waivers.

PTJ: Cognitive Functional Therapy Shows Promise for Chronic LBP Post-Surgery

Oct 13, 2023/Review

A small-scale study from Brazil points to lower levels of pain and higher function compared with a core exercise and manual approach.

Harris Infant Neuromotor Test (HINT)

Jul 12, 2021/Test & Measure

The Harris Infant Neuromotor Test (HINT) is a screening tool designed to identify neuromotor or cognitive/behavioral concerns in infants who are healthy or at high risk between the ages of 3 and 12 months.